Form 4: Phreesia SVP, Life Sciences, David Linetsky, Disposes of Shares to Cover Tax Obligations

David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold 24 shares of common stock to cover tax obligations related to a restricted stock unit settlement.

Summary

• David Linetsky, a Senior Vice President at Phreesia, Inc., sold 24 shares of common stock on December 18, 2024.
• The sale was executed to cover tax withholding obligations associated with the settlement of a restricted stock unit award.
• The shares were sold at a weighted average price of $25.376, with individual transaction prices ranging from $24.86 to $25.58 per share.
• Following the transaction, Mr. Linetsky directly owns 188,354 shares of Phreesia common stock and indirectly owns 8,851 shares through his spouse.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment.

Industry Context

This is a routine transaction for corporate insiders who receive equity compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• The sale of shares by executives to cover tax obligations is a common practice across publicly traded companies.
• The price range of $24.86 to $25.58 per share is within the typical trading range for Phreesia stock at the time of the transaction.
• Similar transactions are regularly reported by executives at comparable companies in the technology and healthcare sectors.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small sale of shares by an executive.
• The sale does not affect the company's operations or financial position.

Key Dates

Keywords

Phreesia, insider trading, Form 4, stock sale, David Linetsky, restricted stock units, tax obligations, equity securities